The Collaborative immunology CRO
Enriching your team
We can tell your molecule’s story
Our mission is to unlock discoveries and develop solutions for biopharmaceutical companies seeking to overcome substantial scientific challenges by providing data of outstanding quality
We’re so pleased to announce that in 2023 we’ll be exhibiting and presenting at two prestigious conferences:
A transformational, inducible cell system that allows selection of the safest and most efficacious targeted therapies. IndEx-2 is an in vitro cell-based platform that provides inducible expression of any target antigen of interest (TAOI).
IndEx-2 is an effective tool that can be used to enhance a pre-clinical data package with information that offers a more comprehensive understanding of a targeted drug mechanism of action and functional profile.
Read our latest news and browse our scientific resource articles
Our latest new development is the launch of our transformative inducible cell line development platform: IndEx-2.
The 29th of May – 2nd of June marks ‘Discovery Week’ here at Antibody Analytics. A chance for us to celebrate as a team and promote discovery throughout the wider industry. Since cutting the ribbon on the Discovery Centre in May 2022, we've achieved some amazing milestones, and we're excited to share them with you.
Our Treg suppression assay formats are adaptable, using natural Tregs isolated from PBMCs, or induced Tregs expanded and differentiated from naïve CD4+ T cells.
Regulatory T cells (thymically and peripherally derived Treg) have critical roles in maintaining immune homeostasis and controlling aberrant/excessive responses to self and non-self antigens.